Press

February 3, 2026

Orthopedic Medical Technology Company Celebrates Grand Opening of U.S. Headquarters With Business, Government and Healthcare Leaders

September 16, 2025

Fast-Growing Orthopedics Company OSSIO Selects Florida for U.S. Headquarters and About 100 New Jobs

June 16, 2025

OSSIO Launches Small OSSIOfiber^® Suture Anchors, Expanding Best-in-Class Portfolio of Bio-Integrative, Metal-Free Implants to Improve Soft Tissue Fixation

December 2, 2024

OSSIO Raises $27.6 Million to Accelerate Its Commercial Engine as High Demand for Bio-Integrative Fixation Technology Continues

November 14, 2024

OSSIO introduces OSSIOfiber^® Threaded Trimmable Fixation Nail to improve orthopedic surgery and simplify inventory management

June 19, 2024

OSSIO expands portfolio of highly differentiated bio-integrative fixation implants with small compression staples to enhance bunion repair patients’ satisfaction

December 6, 2023

OSSIO’s Groundbreaking Option for Fixing Bone Fractures In Children Receives FDA Clearance

February 7, 2023

OSSIO Launches World’s First and Only Non-Permanent Compression Staple

October 17, 2022

OSSIO Closes Series C Financing of $38.5 Million

Proceeds will be used to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber^® implants and accelerate new product platforms into the major orthopedic fixation markets.

March 22, 2022

OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology

OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, receives Vizient contract for bio-integrative orthopedic technology.

November 2, 2021

OSSIO Appoints Gregory C. Berlet, MD, as Chief Medical Officer

March 22, 2021

OSSIO Announces U.S. Launch and First Commercial Use of the Bio-Integrative OSSIOfiber^® Compression Screw Portfolio

October 19, 2020

OSSIO Awarded FDA 510(k) Clearance for OSSIOfiber^® Compression Screw Portfolio

Company Successfully Surpasses 1,000th Implantation Milestone for its Strong and Bio-integrative OSSIOfiber^® Technology

July 22, 2020

OSSIO Announces U.S. Launch and First Commercial Use of the OSSIOfiber^® Trimmable Fixation Nail System for Broad Utilization in Foot/Ankle and Hand/Wrist Procedures

New biointegrative system offers screw-like stability with the utility of a trimmable nail, leaving no permanent implant behind.

April 8, 2020

OSSIO Appoints Healthcare Industry Veteran Gary J. Pruden to Board of Directors

OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment of Gary J. Pruden to its Board of Directors. Pruden.

March 13, 2020

OSSIO Receives FDA 510(k) Clearance for OSSIOfiber^® Hammertoe Fixation System

Complete Offering of Implant Sizes and Shapes Provides Surgeons and their Patients an Intelligent Bone Regeneration Alternative to Metal Fixation

June 11, 2019

OSSIO Receives Prestigious Frost & Sullivan New Product Innovation Award for its Breakthrough OSSIOfiber^® Intelligent Bone Regeneration Technology

Award recognizes company’s dedication to transforming the orthopedic market through its first-of-kind bio-integrative bone fixation solution

May 16, 2019

OSSIO Announces U.S. Launch and First Commercial Use of the New OSSIOfiber^® Bone Pin for Hammertoe Correction

The first commercial cases were hammertoe repairs successfully performed at Polaris Surgery Center in Westerville, Ohio.

March 11, 2019

OSSIO secures $22 million in financing

OSSIO, an orthopedic fixation company, today announced the closing of $22 million in equity financings led by OCV Partners, a Los Angeles based venture capital firm, with continued participation from existing investors Ortho Vision LLC and Secocha Ventures.

January 14, 2019

OSSIO Receives FDA 510(k) Clearance for OSSIOfiber^® Bone Pin Product Family

OSSIO, an orthopedic fixation company, today announced that its OSSIOfiber^® Bone Pin Family has received 510(k)  market clearance from the U.S. Food and Drug Administration (FDA).